Condensed Statement of Changes in Shareholders’ Equity (Deficit) (Unaudited) - 3 months ended Mar. 31, 2026 - USD ($)	Class A Ordinary Shares	Class B Ordinary Shares		Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2025		$ 383		$ 24,617	$ (47,696)	$ (22,696)
Balance (in Shares) at Dec. 31, 2025		3,833,333	[1]
Accretion for Class A ordinary shares to redemption amount				(3,276,693)		(3,276,693)
Sale of Private Placement Units	$ 20			1,999,980		2,000,000
Sale of Private Placement Units ( in Shares)	200,000		[1]
Fair value of Representative Shares	$ 50			369,950		370,000
Fair value of Representative Shares (in Shares)	500,000		[1]
Fair value of Public Rights included in Public Shares				1,800,000		1,800,000
Forfeiture Founder Shares	$ (65)			65
Forfeiture Founder Shares (in Shares)	(650,000)		[1]
Reissuance of Founder Shares	$ 65			4,160		4,225
Reissuance of Founder Shares (in Shares)	650,000		[1]
Allocated value of transaction costs to Class A ordinary shares				(33,995)		(33,995)
Net income					12,001	12,001
Balance at Mar. 31, 2026	$ 70	$ 383		$ 888,084	$ (35,695)	$ 852,842
Balance (in Shares) at Mar. 31, 2026	700,000	3,833,333	[1]

[1] Includes up to 500,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On May 3, 2026, the underwriters forfeited the remaining unexercised balance of 1,500,000 additional Units in connection with the expiration of the over-allotment option. As a result of the forfeiture of the unexercised over-allotment option by the underwriters, 500,000 Founder Shares were forfeited by the Sponsor for no consideration (see Note 5).